Effect of Jak2 Inhibitor AG490 on Osteoclast Differentiation / 대한해부학회지
Korean Journal of Anatomy
;
: 265-270, 2008.
Article
in Korean
| WPRIM
| ID: wpr-645204
ABSTRACT
Osteoclasts are cells of hemopoietic origin that play an critical role in bone resorption and responsible for bone diseases, including osteoporosis, periodontal disease, and rheumatoid arthritis. In this study, we examined the effect of AG490, a Jak2-specific inhibitor on osteoclast differentiation. AG490 significantly inhibited receptor activator of NF-kappaB ligand (RANKL)-mediated osteoclast differentiation in a dose-dependent manner. RANKL stimulated the phosphorylation of p38, ERK, and JNK and promoted I-kappaB degradation. However, AG490 suppressed the phosphorylation of p38 induced by RANKL treatment. AG490 suppressed the mRNA expression of TRAP, c-Fos, NFATc1, and OSCAR in bone marrow-derived macrophages (BMMs) treated with RANKL. Also, AG490 significantly inhibited the protein expression of c-Fos and NFATc1 in response to RANKL. These results suggest that AG490 inhibited osteoclast differentiation by suppressing the expression of c-Fos and NFATc1.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Osteoclasts
/
Osteoporosis
/
Periodontal Diseases
/
Phosphorylation
/
Arthritis, Rheumatoid
/
Bone Diseases
/
Bone Resorption
/
RNA, Messenger
/
Tyrphostins
/
Receptor Activator of Nuclear Factor-kappa B
Language:
Korean
Journal:
Korean Journal of Anatomy
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS